Last edition
News about " implantable neuromodulation therapies"
Enspire DBS Therapy Raises USD 10.3M Series B1 to Advance Post-Stroke Neuromodulation Trial
The funding led by Genesys Capital will support continued enrollment in Enspire’s pivotal restore clinical trial evaluating deep brain stimulation combined with rehabilitation for stroke recovery.
Implantable Neuromodulation Therapies | 14/01/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members